Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -.--% | -82.78% |
Apr. 29 | Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 | CI |
Apr. 22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Sales 2023 | 40.16M 43.46M | Sales 2024 * | 43.9M 47.51M | Capitalization | 14.93M 16.15M |
---|---|---|---|---|---|
Net income 2023 | -174M -188M | Net income 2024 * | -55M -59.52M | EV / Sales 2023 | 9.88 x |
Net Debt 2023 | 310M 336M | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.34 x |
P/E ratio 2023 * |
-0.16
x | P/E ratio 2024 * |
-
| Employees | 270 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.67% |
1 day | -1.82% | ||
1 month | -2.48% | ||
3 months | -59.93% | ||
6 months | -81.38% | ||
Current year | -82.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 17-02-22 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 23-05-28 |
Christian Homsy
CHM | Chairman | 65 | 23-05-28 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 21-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 0.216 | -.--% | 0 |
24-05-21 | 0.216 | -.--% | 0 |
24-05-20 | 0.216 | -.--% | 0 |
24-05-17 | 0.216 | -.--% | 0 |
24-05-16 | 0.216 | -.--% | 0 |
Real-time Euronext Bruxelles, April 26, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.17M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-15.08% | 32.79B | |
+64.13% | 26.23B | |
-22.01% | 14.52B | |
-7.72% | 13.09B | |
-42.60% | 11.6B | |
-12.64% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- MITRA Stock